GL1X · GenesisL1 explorer

Research workbench

The novel P300/CBP inhibitor a-485 uncovers a unique mechanism of action to target ar in castrate resistant prostate cancer

Analyse The novel P300/CBP inhibitor a-485 uncovers a unique mechanism of action to… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5KJ2
Type
protein
Length
323 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone acetyltransferase P300
EC
2.3.1.48
UniProt
Q09472
Ligands
6TF, NA
Pockets
3 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone acetyltransferase P300 (EC 2.3.1.48)protein32343% helix, 20% strandQ09472

Ligands and binding sites

  • 6TF · N-[(4-fluorophenyl)methyl]-2-{(1R)-5-[(methylcarbamoyl)amino]-2',4'-dioxo-2,3-dihydro-3'H-spiro[indene-1,5'-[1,3]oxazolidin]-3'-yl}-N-[(2S)-1,1, 1-trifluoropropan-2-yl]acetamide · ligand · chains A
  • NA · Sodium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14290.760.85466TF, NA
21980.580.8033empty
3790.360.7614empty

Compared structures

  • 5KJ2 · The novel p300/CBP inhibitor A-485 uncovers a unique mechanism of action to target AR in… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q09472 · AlphaFold monomer V2.0 prediction for histone acetyltransferase P300 (Q09472) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.